Together for a better life
with alpha-1-antitrypsin deficiency
Find out all about the latest developments, events and initiatives of the Alpha-1 Europe Alliance. Together we are committed to education, research and support for those affected. Stay informed and become part of our dedicated community!
The European Medicines Agency (EMA) officially confirmed that A1EA meets all the criteria to become an eligible patients' and consumers' organisation, marking an important milestone in the Alliance's development and recognition at the European level.
- published on
- Author: alpha1europe
International experts unite in Lyon, France, to strengthen diagnosis, treatment, and follow-up standards for children affected by Alpha-1 Antitrypsin Deficiency liver disease
- published on
- Author: alpha1europe
The Alpha-1 Europe Alliance marks a key milestone with the launch of its Scientific Advisory Board (SAB), marking an important milestone in strengthening scientific collaboration and ensuring that the patient voice remains at the centre of advances in Alpha-1 Antitrypsin Deficiency (AATD).
- published on
- Author: alpha1europe
The European Medicines Agency (EMA) officially confirmed that A1EA meets all the criteria to become an eligible patients' ...
- published on
- Author: alpha1europe
International experts unite in Lyon, France, to strengthen diagnosis, treatment, and follow-up standards for children affected by Alpha-1 ...
- published on
- Author: alpha1europe
The Alpha-1 Europe Alliance marks a key milestone with the launch of its Scientific Advisory Board (SAB), marking ...
- published on
- Author: alpha1europe
The European Alpha-1 community is coming together through a new initiative supported by the European Lung Foundation (ELF), ...
- published on
- Author: alpha1europe
Representatives of the Alpha-1 Europe Alliance participated in the International Plasma Protein Congress 2026, held in Milan, Italy, ...
- published on
- Author: alpha1europe
Ahead of the European Alpha-1 Awareness Day on 25 April, the Alpha-1 Europe Alliance (A1EA) organised a high-level ...
- published on
- Author: alpha1europe
The European Medicines Agency (EMA) officially confirmed that A1EA meets all the criteria to become an eligible patients' and consumers' organisation, marking an important milestone in the Alliance's development and recognition at the European level.
- Published on
- Author: alpha1europe
International experts unite in Lyon, France, to strengthen diagnosis, treatment, and follow-up standards for children affected by Alpha-1 Antitrypsin Deficiency liver disease
- Published on
- Author: alpha1europe
The Alpha-1 Europe Alliance marks a key milestone with the launch of its Scientific Advisory Board (SAB), marking an important milestone in strengthening scientific collaboration and ensuring that the patient voice remains at the centre of advances in Alpha-1 Antitrypsin Deficiency (AATD).
- Published on
- Author: alpha1europe